"in-depth screening" is a correct and commonly used phrase in written English.
It refers to a thorough and comprehensive process of examining or evaluating something or someone. It is typically used in contexts such as job interviews, medical tests, or security procedures. Example: The company conducted an in-depth screening of all applicants to ensure the best candidates were selected for the job.
We herein describe an in-depth screening and systematic comparison of five classical silyl alkyne protective groups, to evaluate their potential in the context of multiple successive copper (I -catalyzed alkyne–azI -catalyzeditions (Cualkyne azide
Data in the Automated Targeting System is used to decide who is placed on the no-fly list — thousands of people the United States government has banned from flying — and the selectee list, an unknown number of travelers who are required to undergo more in-depth screening, like Mr. Darrat.
Sittercity guides clients through an in-depth screening process of potential caregivers, which includes background checks, references and parent reviews.
This in-depth screening will provide a unique opportunity for the public to enhance their artistic experience while learning about one of the world's most respected professional ballet companies and the specific pieces brought to this venue, company officials said.
5) We did not carry out an in-depth screening for NP manifestations among the patients without history for them, therefore although none of them had any of the acute and severe manifestations included among the patients with central and peripheral NPSLE, we cannot exclude that they had mild or subclinical NP manifestations.
Furthermore, prior knowledge of phenodeviants would allow bespoke processing of non-standard tissues and additional standard tissues to facilitate more in-depth screening and validation, respectively.
A more in-depth screen would be required to identify sites of regulatory phosphorylation in TRPA1.
The study protocol called for a standardized, in-depth thyroid screening examination every 2 years.
The findings of this study are limited by the relatively small cohort sizes, the study design being constrained by the costs of the in-depth CVD screening.
Collecting quantitative and qualitative data will provide a more in-depth picture of screening for fragile X syndrome.
The merits of the classification system described above are that it allows a quick determination of whether an in-depth analysis of screen parameters is required to follow screen progress.
